Skip to main content
. 2021 Oct 9;29:100809. doi: 10.1016/j.ymgmr.2021.100809

Fig. 6.

Fig. 6

Clinical course of patient 2 during the diet therapy.

In patient 2, diet therapy 1 is administered. Following the diet therapy, hypotonia improves and the levels of metabolites, especially S-(2-carboxypropyl)cysteine (SCPC) and S-(2-carboxypropyl)cysteamine (SCPCM) decrease.